41 A randomized managed trial illustrated the improvement of liver capabilities and reduction of serious bacterial infections in clients with hepatitis B virus-relevant ACLF receiving allogeneic bone marrow-derived MSCs (BM-MSCs) via peripheral infusion.42 HSCs from peripheral blood after the G-CSF